Analyst Ratings For SI-BONE
Portfolio Pulse from Benzinga Insights
SI-BONE (NASDAQ:SIBN) has received mixed analyst ratings over the past three months, with a recent trend towards lowering price targets. The average 12-month price target has dropped by 17.2% to $19.25. Despite strong revenue growth, the company faces challenges with profitability and asset utilization.
August 06, 2024 | 6:01 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
SI-BONE has received mixed analyst ratings with a recent trend towards lowering price targets. The average 12-month price target has dropped by 17.2% to $19.25. Despite strong revenue growth, the company faces challenges with profitability and asset utilization.
The recent trend of analysts lowering their price targets for SI-BONE indicates a bearish sentiment. Despite the company's strong revenue growth, challenges in profitability and asset utilization are likely contributing to the negative outlook. This could lead to a short-term decline in the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100